Previous 10 | Next 10 |
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire – 34% year-over-year growth in 2023 total revenue – – Global filings of sepiapterin remain on track with first submission of the ...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results PR Newswire SOUTH PLAINFIELD, N.J. , Feb. 15, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast c...
2024-02-12 16:46:59 ET More on Biogen Biotech And Pharma Diversification Pays Off Biogen Inc. (BIIB) JPMorgan 42nd Annual Healthcare Conference (Transcript) Biogen: LEQEMBI's $10 Billion Potential Biogen Q4 2023 Earnings Preview Biogen scraps Aduhelm,...
2024-02-11 18:00:00 ET Summary PTC Therapeutics has a diverse portfolio and pipeline of drugs, including a broader DMD treatment. The company has not fully expanded its revenue-generating products geographically and is in the process of making the necessary submissions to do so. ...
2024-01-31 00:21:00 ET Summary Q4 marks the end of a difficult year for Russell 2000 earnings. Energy is no longer the 'top dog' from an earnings growth contribution perspective. Financials has the largest earnings weight for the second consecutive quarter. By Taji...
2024-01-25 17:30:32 ET More on PTC Therapeutics PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Call Transcript PTC Therapeutics says total unaudited FY23 net revenue was about $946M PTC Therapeutics issues EU, US regulatory updates on Translarna Seeking Alpha...
2024-01-25 16:59:42 ET Gainers: Ocular Therapeutix, ( OCUL ) +5% . AppFolio ( APPF ) +4% . Sagimet Biosciences ( SGMT ) +3% . Xcel Energy ( XEL ) +3% . Digital World Acquisition ( DWAC ) +2% . Losers...
CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) Following Re-examination Procedure PR Newswire SOUTH PLAINFIELD, N.J. , Jan. 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) anno...
2024-01-08 11:40:25 ET More on PTC Therapeutics PTC Therapeutics issues EU, US regulatory updates on Translarna PTC Therapeutics stock slides after Citi downgrades to Sell Seeking Alpha’s Quant Rating on PTC Therapeutics Historical earnings data for PT...
News, Short Squeeze, Breakout and More Instantly...
PTC Therapeutics Inc. Company Name:
PTCT Stock Symbol:
NASDAQ Market:
PTC Therapeutics Inc. Website:
2024-05-03 18:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-01 10:45:03 ET XPeng Inc (XPEV) XPEV is trading UP for the last 5 days, and it at trading at $8.16 with volume of 3,591,457 and a one day change of $0.03 (0.31%). XPeng Inc has a 52-week low of 6.55 and a 52-week high of $23.62. The business's 50-day moving average price is ...
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results PR Newswire – Strong revenue performance across product portfolio – – Submitted MAA for sepiapterin and BLA for Upstaza – – On target ...